The FDA has granted Fast Track designation to Erasca’s investigational [...]

AC Immune has received FDA Fast Track designation and IND [...]

Aravax’s PVX108 has received FDA Fast Track designation as the [...]

Context Therapeutics has reported encouraging interim Phase 1 data for [...]

Alto Neuroscience has received FDA Fast Track designation for its [...]

Morphic Medical’s non-invasive weight loss device RESET is expected to [...]

FDA recognition accelerates development of first-in-class mitochondrial cell therapy for [...]